ALK Gene Mutation Clinical Trials in Changsha, Hunan
2 recruitingChangsha, Hunan, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
Non-small Cell Lung CancerALK Gene MutationEGFR Gene Mutation+2 more
Hunan Province Tumor Hospital6,000 enrolled1 locationNCT04322890
Recruiting
Phase 2
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
Lung AdenocarcinomaImmunotherapyALK Gene Mutation
Hunan Province Tumor Hospital78 enrolled1 locationNCT05266846